Insider Transactions in Q3 2023 at Incyte Corp (INCY)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2023
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
1,020
+0.01%
|
-
|
|
Sep 29
2023
|
Edmund Harrigan Director |
BUY
Grant, award, or other acquisition
|
Direct |
389
+3.07%
|
$22,173
$57.77 P/Share
|
|
Sep 29
2023
|
Paul J Clancy Director |
BUY
Grant, award, or other acquisition
|
Direct |
379
+2.47%
|
$21,603
$57.77 P/Share
|
|
Sep 01
2023
|
Paula J Swain EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
8,449
-9.83%
|
$549,185
$65.13 P/Share
|
|
Aug 01
2023
|
Steven H Stein EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
21,511
-18.06%
|
$1,355,193
$63.28 P/Share
|
|
Jul 14
2023
|
Barry P Flannelly EVP & General Manager US |
BUY
Grant, award, or other acquisition
|
Direct |
9,668
+10.62%
|
-
|
|
Jul 14
2023
|
Steven H Stein EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,535
+10.21%
|
-
|
|
Jul 14
2023
|
Herve Hoppenot Chairman / CEO |
BUY
Grant, award, or other acquisition
|
Direct |
43,184
+9.03%
|
-
|
|
Jul 14
2023
|
Pablo J Cagnoni President, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
9,668
+4.57%
|
-
|
|
Jul 14
2023
|
Vijay K Iyengar EVP, GMAPPS |
BUY
Grant, award, or other acquisition
|
Direct |
7,089
+13.86%
|
-
|
|
Jul 14
2023
|
Maria E Pasquale EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
9,668
+12.18%
|
-
|
|
Jul 14
2023
|
Paula J Swain EVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
7,089
+7.62%
|
-
|
|
Jul 14
2023
|
Dashyant Dhanak EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,056
+12.02%
|
-
|
|
Jul 14
2023
|
Christiana Stamoulis EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,246
+12.86%
|
-
|
|
Jul 14
2023
|
Thomas Tray Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,015
+19.69%
|
-
|
|
Jul 03
2023
|
Dashyant Dhanak EVP & Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,044
-10.61%
|
$374,728
$62.08 P/Share
|
|
Jul 03
2023
|
Vijay K Iyengar EVP, GMAPPS |
SELL
Payment of exercise price or tax liability
|
Direct |
6,215
-14.39%
|
$385,330
$62.08 P/Share
|
|
Jul 03
2023
|
Steven H Stein EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,442
-7.41%
|
$523,404
$62.08 P/Share
|
|
Jul 03
2023
|
Maria E Pasquale EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
8,468
-12.36%
|
$525,016
$62.08 P/Share
|
|
Jul 03
2023
|
Christiana Stamoulis EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,073
-7.91%
|
$376,526
$62.08 P/Share
|
|
Jul 03
2023
|
Thomas Tray Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,136
-5.78%
|
$70,432
$62.08 P/Share
|
|
Jul 03
2023
|
Paula J Swain EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
5,783
-6.83%
|
$358,546
$62.08 P/Share
|
|
Jul 03
2023
|
Barry P Flannelly EVP & General Manager US |
SELL
Payment of exercise price or tax liability
|
Direct |
6,304
-8.08%
|
$390,848
$62.08 P/Share
|
|
Jul 03
2023
|
Herve Hoppenot Chairman / CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
43,467
-9.99%
|
$2,694,954
$62.08 P/Share
|